Dark

DVAX
Dynavax Technologies Corporation
stock NASDAQ

At Close

Nov 20, 2025 3:59:56 PM EST

10.79USD-2.353%(-0.26)2,161,285

0.00Bid 0.00Ask 0.00Spread

Pre-market

Nov 20, 2025 9:11:30 AM EST

11.20USD+1.357%(+0.15)607

After-hours

Nov 20, 2025 4:00:30 PM EST

10.80USD+0.093%(+0.01)2,911

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

1.27B

Headquarters

Emeryville, California, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Feb 19, 2026 (90d)

Last Split

Nov 10, 20141for10reverse

GILD BIIB MNTA AZN GSK PFE MRK AGEN VICL XLV

DVAX Stats

Avg. Vol. 10 Day

2,046,419

Avg. Vol. 30 Day

1,588,514

Employees

192

Market Cap

1,267,015,405

Shares Out.

117,424,968

On/Off Exchange

61%/39%

6 Month Beta

0.69

1 Year Beta

0.48

2 Year Beta

0.48

3 Year Beta

0.65

52 Week Low

9.20

52 Week High

14.63

SMA50

10.21

SMA200

11.04

1 Week

-3.32%

1 Month

+7.20%

3 Month

+3.55%

6 Month

+3.55%

1 Year

-11.34%

2 Year

-21.13%

5 Year

+144.12%

Profile

dynavax technologies corporation is a clinical-stage biopharmaceutical company that develops products to prevent and treat infectious and inflammatory diseases and cancer. our clinical-stage product candidates include: phase 3 heplisav-b ™ adult hepatitis b vaccine phase 1/2 cancer immunotherapy phase 2 asthma therapy - partnered with astrazeneca in europe, dynavax manufactures hepatitis b surface antigen for heplisav-b.

DVAX Stock Summary

Dynavax Technologies Corporation (NASDAQ:DVAX) stock price today is $10.79, and today's volume is 2,161,285. DVAX is down -2.353% today. The 30 day average volume is 1,588,514. DVAX market cap is 1.27B with 117,424,968 shares outstanding.